Pacific Biosciences of California PACB Gains (Losses) on Restructuring of Debt
Gains (Losses) on Restructuring of Debt at other companies
Segments
By segment
Other financials
Where this comes from
Reported directly by Pacific Biosciences of California in its filing.
Tagged under the XBRL concept us-gaap:GainsLossesOnRestructuringOfDebt.
The official record: Pacific Biosciences of California’s 10-K, filed February 25, 2026, on SEC EDGAR. View the filing →
Ask your AI about Pacific Biosciences of California's gains (losses) on restructuring of debt.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Pacific Biosciences of California's gains (losses) on restructuring of debt?
- Pacific Biosciences of California (PACB) reported gains (losses) on restructuring of debt of $0 in Q4 2025.
- How has Pacific Biosciences of California's gains (losses) on restructuring of debt changed year-over-year?
- Pacific Biosciences of California's gains (losses) on restructuring of debt decreased by 100.0% year-over-year, from $38.6M to $0.
- What does gains (losses) on restructuring of debt mean?
- Reflects the non-cash gains or losses recognized when a company modifies or extinguishes its debt obligations. It provides insight into the impact of capital structure adjustments on the company's financial position.